Druck Icon

Eckert & Ziegler Doubles it’s Nine Month Revenues

(Ad hoc press release)

Berlin, 15.11.2000. Eckert & Ziegler AG, a specialist for the provision of miniaturized, low-level radiation sources for the treatment of cancer and cardiovascular diseases continued it’s expansion in the third quarter of 2000. The company increased it’s revenues by 124% to 15.9 Mio EUR (7.1 Mio EUR) compared with the prior year period. Results from ordinary activities climbed by 287% to 2.1 Mio EUR (0.6 Mio EUR). Cash flow rose by 153% to 4.6 Mio EUR (1,8 Mio EUR). Encouragingly enough, all segments contributed to driving this sales growth with the 400% increase marked up by Oncology standing out by comparison with the previous year. The other product areas, Cardiology, Medical Reference Sources and Science and Industry, were each able to approximately double their sales. The quarter is the sixth consecutive quarter in which revenue have more then doubled in comparison to the previous year. The management team is confident that it will substantially exceed the 2000 revenue target of 19.1 Mio EUR that was announced earlier this year. It also expects to reach the after-tax results of 2.1 Mio EUR, since there will be a number of milestone payments related to project completions.

The Board of Directors